Abstract
This paper describes the optimization of designing a two-dimensional (2-D) ultrasound phased array to be used for the treatment of both prostate cancer and benign prostatic hyperplasia. The optimization study took into consideration the physical constraints of the conventional method of treatment, and arrived at an optimized array design with the overall dimensions of 10 cm × 2.2 cm. The optimization study also addressed the following additional parameters: The maximum possible depth of penetration (DOP), the maximum possible steering angle, the Grating lobe level, the operating frequency, and the element size. In optimizing the design, the DOP and the steering angle are maximized while the grating lobe value is minimized. A 56 × 12 element 2-D array was found to be the optimum choice allowing both focusing and steering within the entire prostate without inducing damage at locations other than that of the focal point.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Astrahan M, Sapozink M, Cohen D et al (1989) Microwave applicator for transurethral hyperthermia of benign prostatic hyperplasia. Int J Hyperthermia 5:283–296. doi:10.3109/02656738909140455
Curiel L, Chavrier F, Souchon R et al (2002) 1.5-D high intensity focused ultrasound array for non-invasive prostate cancer surgery. IEEE Trans Ultrason Ferr 49(2):231–242. doi:10.1109/58.985707
Hutchinson E (1997) Intracavitary ultrasound phased arrays for thermal therapies [PhD dissertation]. Massachusetts Institute of Technology, Cambridge
Hutchinson E, Hynynen K (1996) Intracavitary phased arrays for non-invasive prostate surgery. IEEE Trans Ultrason Ferr 43:1032–1042. doi:10.1109/58.542048
Hutchinson E, Buchanan M, Hynynen K (1996) Design and optimization of an aperiodic ultrasound phased array for intracavitary prostate thermal therapies. Med Phys 23(5):767–776. doi:10.1118/1.597741
Lee R, Buchanan M, Kleine L et al (1999) Arrays of multielement ultrasound applicators for interstitial hyperthermia. IEEE Trans Bio Med Eng 46(7):880–890
Lu M, Wan M, Xu F et al (2006) Design and experiment of 256-element ultrasound phased array for noninvasive focused ultrasound surgery. Ultrasonics 44(1):e325–e330. doi:10.1016/j.ultras.2006.07.015
Saleh K, Smith N (2004) Two dimensional ultrasound phased array design for tissue ablation for treatment of benign prostatic hyperplasia. Int J Hyperthermia 20(1):7–31. doi:10.1080/0265673031000150867
Saleh K, Smith N (2005) A 63 element 1.75 dimensional ultrasound phased array for the treatment of benign prostatic hyperplasia. Biomed Eng Online 4:39
Saleh K, Smith N (2006) Design and evaluation of a 3 × 21 element 1.75 dimensional tapered ultrasound phased array for the treatment of prostate disease. Mater Res Innov 10(2):62–65
Sokka S, Hynynen K (2000) The feasibility of MRI guided whole prostate ablation with a linear aperoidic intracvitary ultrasound phased array. Phys Med Biol 45:3373–3383. doi:10.1088/0031-9155/45/11/319
Sokka S, King R, McDannold N et al (1999) Design and evaluation of linear intracavitary ultrasound phased array for MRI-guided prostate ablative therapies. Proc IEEE 2:1435–1438
Stephens F (2000) All about prostate cancer. Oxford University Press, South Melbourne
Tan J, Frizzell L, Sanghvi N et al (2000) Design of focused ultrasound phased arrays for prostate treatment. Proc IEEE 2:1247–1251
Zemanek J (1971) Beam behavior within the nearfield of a vibrating piston. J Acoust Soc Am 49:181–191. doi:10.1121/1.1912316
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lweesy, K., Fraiwan, L., Al-Bataineh, O. et al. Optimization of ultrasound array designs for high intensity focused treatment of prostate cancer and benign prostatic hyperplasia. Med Biol Eng Comput 47, 635–640 (2009). https://doi.org/10.1007/s11517-009-0478-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11517-009-0478-4